Faeth Therapeutics (FTH) Other Non-Current Assets (2020 - 2026)

Faeth Therapeutics (FTH) has reported Other Non-Current Assets for 7 consecutive years, with $80000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 233.33% year-over-year to $80000.0; the trailing twelve-month figure through Jun 2026 stood at $80000.0 (up 233.33% YoY), and the FY2025 full-year result was $18000.0, down 62.5% from the prior year.
• Other Non-Current Assets fell to $80000.0 in Q2 2026 per FTH's latest filing, from $167000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $167000.0 in Q1 2026 and bottomed at $18000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $65000.0 across 5 years, with a median of $71500.0 in 2022.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets sank 79.31% in 2025, then soared 595.83% in 2026.
• Over 5 years, Other Non-Current Assets stood at $63000.0 in 2022, then soared by 36.51% to $86000.0 in 2023, then plunged by 44.19% to $48000.0 in 2024, then plunged by 62.5% to $18000.0 in 2025, then jumped by 344.44% to $80000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $80000.0, $167000.0, and $18000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.